aduvanz 30 mg
2care4 aps - lisdeksamfetamindimesilat - kapsel, hard - 30 mg
methylphenidate aristo 10 mg
aristo pharma gmbh - metylfenidathydroklorid - kapsel med modifisert frisetting, hard - 10 mg
methylphenidate aristo 20 mg
aristo pharma gmbh - metylfenidathydroklorid - kapsel med modifisert frisetting, hard - 20 mg
methylphenidate aristo 30 mg
aristo pharma gmbh - metylfenidathydroklorid - kapsel med modifisert frisetting, hard - 30 mg
rybrevant
janssen-cilag international n.v. - amivantamab - karsinom, ikke-småcellet lunge - antineoplastiske midler - rybrevant as monotherapy is indicated for treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating epidermal growth factor receptor (egfr) exon 20 insertion mutations, after failure of platinum-based chemotherapy.
upstaza
ptc therapeutics international limited - eladocagene exuparvovec - aminosyre-metabolisme, infiserte feil - enzymes, other alimentary tract and metabolism products - upstaza is indicated for the treatment of patients aged 18 months and older with a clinical, molecular, and genetically confirmed diagnosis of aromatic l amino acid decarboxylase (aadc) deficiency with a severe phenotype (see section 5.
balidax 30 mg
teva b.v. - lisdeksamfetamindimesilat - kapsel, hard - 30 mg
balidax 20 mg
teva b.v. - lisdeksamfetamindimesilat - kapsel, hard - 20 mg
balidax 40 mg
teva b.v. - lisdeksamfetamindimesilat - kapsel, hard - 40 mg
balidax 50 mg
teva b.v. - lisdeksamfetamindimesilat - kapsel, hard - 50 mg